These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8438050)

  • 41. Statin-associated myopathy with normal creatine kinase levels. Case report from a Norwegian family.
    Trøseid M; Henriksen OA; Lindal S
    APMIS; 2005 Sep; 113(9):635-7. PubMed ID: 16218940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. First of two parts: a phase I trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipticine analogue.
    Mathé G; Pontiggia P; Orbach-Arbouys S; Triana K; Ambetima N; Morette C; Hallard M; Blanquet D
    Biomed Pharmacother; 1996; 50(5):220-7. PubMed ID: 8949403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enzyme elevation in patients with juvenile dermatomyositis and steroid myopathy.
    Naim MY; Reed AM
    J Rheumatol; 2006 Jul; 33(7):1392-4. PubMed ID: 16821273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIV or zidovudine myopathy?
    Grau JM; Casademont J
    Neurology; 1994 Feb; 44(2):361; author reply 362-4. PubMed ID: 8309595
    [No Abstract]   [Full Text] [Related]  

  • 45. Outcomes in 45 patients with statin-associated myopathy.
    Hansen KE; Hildebrand JP; Ferguson EE; Stein JH
    Arch Intern Med; 2005 Dec 12-26; 165(22):2671-6. PubMed ID: 16344427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy.
    Whitfield RM; Bechtel LM; Starich GH
    Alcohol Clin Exp Res; 1997 Feb; 21(1):122-7. PubMed ID: 9046384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuromuscular complications of human immunodeficiency virus infection and antiretroviral therapy.
    Miller RG
    West J Med; 1994 May; 160(5):447-52. PubMed ID: 8048229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Mitochondrial myopathy and mitochondrial encephalomyopathy].
    Song D; Liu C; Lu Q; Shi J; Chen J; Zhang H; Zhang Y; Wang H; Zhang W; Li G
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):158-60. PubMed ID: 11953149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transient visual loss due to severe anemia in a patient with AIDS.
    Luchi M; Warren KA; Saberhagen C; Hinthorn D
    J La State Med Soc; 1999 Feb; 151(2):82-5. PubMed ID: 11280841
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy.
    Arnaudo E; Dalakas M; Shanske S; Moraes CT; DiMauro S; Schon EA
    Lancet; 1991 Mar; 337(8740):508-10. PubMed ID: 1671889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tubular aggregates and partial cytochrome c oxidase deficiency in skeletal muscle of patients with AIDS treated with zidovudine.
    Chariot P; Benbrik E; Schaeffer A; Gherardi R
    Acta Neuropathol; 1993; 85(4):431-6. PubMed ID: 8386898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial.
    Foudraine NA; Jurriaans S; Weverling GJ; Burger DM; Hoetelmans RM; Roos MT; Maas J; Miedema F; Reiss P; Portegies P; de Wolf F; Lange JM
    Antivir Ther; 2001 Mar; 6(1):55-62. PubMed ID: 11417762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency.
    Lalani SR; Vladutiu GD; Plunkett K; Lotze TE; Adesina AM; Scaglia F
    Arch Neurol; 2005 Feb; 62(2):317-20. PubMed ID: 15710863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.
    Mathez D; Bagnarelli P; Gorin I; Katlama C; Pialoux G; Saimot G; Tubiana P; De Truchis P; Chauvin JP; Mills R; Rode R; Clementi M; Leibowitch J
    Antivir Ther; 1997 Jul; 2(3):175-83. PubMed ID: 11322272
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Muscle carnitine deficiency and lipid storage myopathy in patients with mitochondrial myopathy.
    Campos Y; Huertas R; Bautista J; Gutiérrez E; Aparicio M; Lorenzo G; Segura D; Villanueva M; Cabello A; Alesso L
    Muscle Nerve; 1993 Jul; 16(7):778-81. PubMed ID: 8505934
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognosis in AZT myopathy.
    Chalmers AC; Greco CM; Miller RG
    Neurology; 1991 Aug; 41(8):1181-4. PubMed ID: 1714057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Mitochondrial toxicity: a case of palpebral ptosis in a woman infected by HIV and treated with HAART including zidovudine].
    Zannou DM; Azon-Kouanou A; Bashi BJ; Gougounon A; Zinsou R; Adé G; Houngbè F
    Bull Soc Pathol Exot; 2009 May; 102(2):97-8. PubMed ID: 19583030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early versus deferred zidovudine monotherapy: impact on AIDS-free time and survival in the multicenter AIDS cohort study.
    Detels R; Muñoz A; Peng Y; Graham N; Mellors J; Phair J
    Antivir Ther; 1997 Jan; 2(1):21-9. PubMed ID: 11322263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic, hepatic and muscular changes during zidovudine therapy: a drug-induced mitochondrial disease?
    Le Bras P; D'Oiron R; Quertainmont Y; Halfon P; Caquet R
    AIDS; 1994 May; 8(5):716-7. PubMed ID: 8060560
    [No Abstract]   [Full Text] [Related]  

  • 60. HIV or zidovudine myopathy?
    Gherardi R; Chariot P
    Neurology; 1994 Feb; 44(2):361-2; author reply 362-4. PubMed ID: 8309597
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.